Cutaneous melanoma: How does ultraviolet light contribute to melanocyte transformation?

Future Oncology

Volumn 4, Issue 6, 2008, Pages 841-856

  Walker, Graeme ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Melanocytes; Melanoma; Pigmentation; Sun sensivitiy; Ultraviolet radiation

Indexed keywords

ALPHA INTERMEDIN; ARGININE; B RAF KINASE; CORTICOTROPIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA; ENDOTHELIN RECEPTOR; INTERLEUKIN 18; MELANIN; MELANOCORTIN 1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROLINE; PROTEIN KINASE B; PROTEIN MDM2; PROTEIN P53; RAF PROTEIN; RAS PROTEIN; STEM CELL FACTOR;

AMINO ACID SUBSTITUTION; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CYCLE REGULATION; CELL PROLIFERATION; CHROMOSOMAL INSTABILITY; DNA REPAIR; EPIDEMIOLOGICAL DATA; GENE MUTATION; GENETIC VARIABILITY; HUMAN; IMMUNE DEFICIENCY; MALIGNANT TRANSFORMATION; MELANOCYTE; MELANOMA; NONHUMAN; OXIDATIVE STRESS; PATHOLOGICAL ANATOMY; PHOTOSENSITIZATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; SKIN PIGMENTATION; STEM CELL; SUN EXPOSURE; SUNBURN; ULTRAVIOLET RADIATION; ANIMAL; CELL TRANSFORMATION; PATHOLOGY; RADIATION EXPOSURE; SKIN TUMOR;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MELANOCYTES; MELANOMA; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 61449522301     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.4.6.841     Document Type: Review

References (104)

1. Gandini S, Sera F, Cattaruzza MS et al.: Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur. J. Cancer 41(1), 45-60 (2005).
2. Whiteman DC, Green AC: A risk prediction tool for melanoma? Cancer Epidemiol. Biomarkers Prev. 14(4), 761-763 (2005).
3. Hu S, Ma F, Collado-Mesa F, Kirsner RS: UV radiation, latitude, and melanoma in US hispanics and blacks. Arch. Dermatol. 140(7), 819-824 (2004).
4. Rigel DS: Cutaneous ultraviolet exposure and its relationship to the development of skin cancer. J. Am. Acad. Dermatol. 58(5), S129-S132 (2008).
5. Sturm RA, Box NF, Ramsay M: Human pigmentation genetics: the differences is only skin deep. Bioessays (9), 712-721 (1998).
6. Walker G, Kimlin M, Hacker E et al.: Murine neonatal melanocytes exhibit a heightened proliferative response to ultraviolet radiation and migrate to the epidermal basal layer. J. Invest. Dermatol. DOI 10:1038/jid.2008.210 (2008) (Epub ahead of print).
7. Costin GE, Hearing VJ: Human skin pigmentation: melanocytes modulate skin color in response to stress. FASEB J. 21(4), 976-994 (2007).
8. Hirobe T: Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res. 18(1), 2-12 (2005).
9. Lin J, Fisher DE: Melanocyte biology and skin pigmentation. Nature 445, 843-850 (2007).
10. Böhn M, Wolff I, Scholzen TE et al.: α-melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J. Biol. Chem. 280(7), 579-5802 (2005).
11. Kadekaro AL, Kavanagh R, Kanto H et al.: α-melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res. 65(10), 4292-4299 (2005).
12. Hauser JE, Kadekaro AL, Kavanagh RJ et al.: Melanin content and MC1R function independently affect UVR-induced DNA damage in cultured human melanocytes. Pigment Cell Res. 19(4), 303-314 (2006).
13. Whiteman DC, Watt P, Purdie DM, Hughes MC, Hayward NK, Green AC: Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J. Natl Cancer Inst. 95(11), 806-812 (2003).
14. English DR, Milne E, Simpson JA: Ultraviolet radiation at places of residence and the development of melanocytic nevi in children (Australia). Cancer Causes Control 17(1), 103-107 (2006).
15. van Schanke A, van Venrooij GM, Jongsma MJ et al.: Induction of nevi and skin tumors in Ink4a/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures. Cancer Res. 66(5), 2608-2615 (2006).
16. Carli P, Palli D: Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J. Natl Cancer Inst. 95(23), 1801 (2003).
17. Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE: Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program. J. Invest. Dermatol. 128(5), 1340-1342 (2008).
18. Curtin JA, Fridlyand J, Kageshita T et al.: Distinct sets of genetic alterations in melanoma. N. Engl. J. Med. 353(20), 2135-2147 (2005).
19. Maldonado JL, Fridlyand J, Patel H et al.: Determinants of BRAF mutations in primary melanomas. J. Natl Cancer Inst. 95(24), 1878-1890 (2003).
20. Saldanha G, Potter L, Daforno P, Pringle JH: Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies. Clin. Cancer Res. 12(15), 4499-4505 (2006).
21. Hacker E, Muller K, Whiteman DC, Ravey S, Hayward N, Walker C: Reduced expression of IL-18 is a marker of ultraviolet radiation-induced melanomas. Int. J. Cancer 123(1), 227-231 (2008).
22. Whiteman DC, Parsons PC, Green AC: p53 expression and risk factors for cutaneous melanoma: a case-control study. Int. J. Cancer 77(6), 843-848 (1998).
23. Purdue MP, From L, Kahn H et al.: Etiologic factors associated with p53 immunostaining in cutaneous malignant melanoma. Int. J. Cancer 117(3), 486-493 (2005).
24. Landi MT, Bauer J, Pfeiffer RM et al.: MC1R germline variants confer risk for BRAF-mutant melanoma. Science 313(5786), 521-522 (2006).
25. Curtin JA, Busam K, Pinkel D, Bastian BC: Somatic activation of KIT in distinct subtypes of melanoma. J. Clin. Oncol. 24(26), 4340-4346 (2006).
26. Larue L, Beermann F: Cutaneous melanoma in genetically modified animals. Pigment Cell Res. 20(6), 485-497 (2007).
27. Noonan FP, Recio JA, Takayama H et al.: Neonatal sunburn and melanoma in mice. Nature 413(6853), 271-222 (2001).
28. Wolnicka-Glubisz A, Damsker J, Constant S, Corn S, De Fabo E, Noonan F: Deficient inflammatory response to UV radiation in neonatal mice. J. Leukoc. Biol. 81(6), 1352-1361 (2007).
29. Gleason BC, Crum CP, Murphy GF et al.: Expression patterns of MITF during human cutaneous embryogenesis: evidence for bulge epithelial expression and persistence of dermal melanoblasts. J. Cutan. Pathol. 35(7), 615-622 (2008).
30. Kannan K, Sharpless NE, Xu J, O'Hagan RC, Bosenberg M, Chin L: Componentsof the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model: Proc. Natl Acad. Sci. USA 100(3), 1221-1225 (2003).
31. R24C/TPras mice. Cancer Res. 66(6), 2946-2952 (2006).
32. Ha L, Ichikawa T, Anver M et al.: ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence. Proc. Natl Acad. Sci. USA 104(26), 10968-10973 (2007).
33. de Gruijl FR, van Kranen HJ, van Schanke A: UV exposure, genetic targets in melanocytic tumors and transgenic mouse models. Photochem. Photobiol. 81(1), 52-64 (2005).
34. Randerson-Moor JA, Harland M, Williams S et al.: A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum. Mol. Genet. 10(1), 55-62 (2001).
35. Rizos H, Puig S, Badenas C et al.: A melanoma-associated germline mutation in exon 1β inactivates p14ARF. Oncogene 20(39), 5543-5547 (2001).
36. Goldstein AM, Struewing JP, Chidambaram A, Fraser MC, Tucker MA: Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations. J. Natl Cancer Inst. 92(12), 1006-1010 (200).
37. Bishop DT, Demenais F, Goldstein AM et al.: Geographical variation in the penetrance of CDKN2A mutations for melanoma. J. Natl Cancer Inst. 94(12), 894-903 (2002).
38. Pavey S, Gabrielli B: α-melanocyte stimulating hormone potentiates p16/CDKN2A expression in human skin after ultraviolet radiation. Cancer Res. 62(3), 875-880 (2002).
39. Sarkar-Agrawal P, Vergilis I, Sharpless NE, DePinho RA, Rünger TM: Impaired processing of DNA photoproducts and ultraviolet hypermutability with loss of p161NK4a or p19ARF. J. Natl Cancer Inst. 96(23), 1790-1793 (2004).
40. Thomas N, Berwick M, Cordeiro M: Could BRAF mutations in melanocytic lesions arise from DNA damage induced by ultraviolet radiation. J. Invest. Dermatol. 126, 1693-1696 (2006).
41. Besaratinia A, Pfeifer G: Sunlight ultraviolet radiation and BRAF V600 mutagenesis in human melanoma. Hum. Mut. 0, 1-9 (2008).
42. Hacker E, Irwin N, Muller K et al.: Neonatal ultraviolet radiation exposure is critical for malignant melanoma induction in pigmented Ipras transgenic mice. J. Invest. Dermatol. 125(5), 1074-1077 (2005).
43. Rees J: The genetics of sun sensitivity in humans. Am. J. Hum. Genet. 75, 739-751 (2004).
44. Palmer JS, Duffy DL, Box NF et al.: Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am. J. Hum. Genet. 66(1), 176-186 (2000).
45. Kennedy C, ter Huurne J, Berkhout M et al.: Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J. Invest. Dermatol. 117(2), 294-300 (2001).
46. Gudbjartsson DF, Sulem P, Stacey SN et al.: ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat. Genet. 40(7), 886-891 (2008).
47. Stefanaki I, Stratigos AJ, Dimisianos G, et al.: p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants. Br. J. Dermatol. 156(2), 357-362 (2007).
48. Hill HZ: The function of melanin or six blind people examine an elephant. Bioessays 14(1), 49-56 (1992).
49. Takeuchi S, Zhang W, Wakamatsu K et al.: Melanin acts as a potent UVB photosensitizer to cause an atypical mode of cell death in murine skin. Proc. Natl Acad. Sci. USA 101(42), 15076-15081 (2004).
50. Scott MC, Wakamatsu K, Ito S et al.: Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation. J. Cell Sci. 115(Pt 11), 2349-2355 (2002).
51. Fernandez LP, Milne RL, Pita G et al.: SLC45A2: a novel malignant melanoma-associated gene. Hum. Mutat. 0, 1-7 (2008).
52. Wehrle-Haller B: The role of Kit-ligand in melanocyte development and homeostasis. Pigment Cell Res. 16(3), 287-296 (2003).
53. Rosengren Pielberg G, Golovko A, Sundstrom E et al.: A cis-acting regulatory mutation causes premature hair greying and susceptibility to melanoma in the horse. Nat. Genet. 40(8), 1004-1009 (2008).
54. Smith AG, Luk N, Newton RA, Roberts DW, Sturm RA, Muscat GE: Melanocortin-1 receptor signaling markedly induces the expression of the NR4A nuclear receptor subgroup in melanocytic cells. J. Mol. Chem. 283(18), 12564-12570 (2008).
55. Kijas JM, Wales R, Törnsten A, Chardon P, Moller M, Andersson L: Melanocortin receptor 1 (MC1R) mutations and coat color in pigs. Genetics 150(3), 1177-1185 (1998).
56. Smith S, Smith SH, Goldschmidt MH et al.: A comparative review of melanocytic neoplasms. Vet. Pathol. 39(6), 651-678 (2002).
57. Tadokoro T, Kobayashi N, Zmudzka BZ et al.: UV-induced DNA damage and melanin content in human skin differing in racial/ethnic origin. FASEB J. 17(9), 1177-1179 (2003).
58. Wood SR, Berwick M, Ley RD, Walter RB, Setlow RB, Timmins GS: UV causation of melanoma in Xiphophorus is dominated by melanin photosensitized oxidant production. Proc. Natl Acad. Sci. USA 103(11), 111-115 (2006).
59. Persad S, Menon IA, Haberman HF: Comparison of the effects of UV-visible irradiation of melanins and melanin-hematoporphyrin complexes from human black and red hair. Photochem. Photobiol. 37(1), 63-68 (1983).
60. Stierner U, Rosdahl I, Augustsson A, Kagedal B: UVB irradiation induces melanocyte increase in both exposed and shielded human skin. J. Invest. Dermatol. 92(4), 561-564 (1989).
61. Scott GA, Haake AR: Keratinocytes regulate melanocyte number in human fetal and neonatal skin equivalents. J. Invest. Dermatol. 97(5), 776-781 (1991).
62. Quevedo W, Fleischmann R: Developmental biology of mammalian melanocytes. J. Invest. Dermatol. 75(1), 116-120 (1980).
63. Rosdahl I, Szabo G: Mitotic activity of epidermal melanocytes in UV-irradiated mouse skin. J. Invest. Dermatol. 70(3), 143-148 (1978).
64. Yamaguchi Y, Coelho SG, Zmudzka BZ et al.: Cyclobutane pyrimidine dimer formation and p53 production in human skin after repeated UV irradiation. Exp. Dermatol. (2008) (Epub ahead of print).
65. Jimbow K, Uesugi T: New melanogenesis and photobiological processes in activation and proliferation of precursor melanocytes after UV-exposure: ultrastructural differentiation of precursor melanocytes from Langerhans cells. J. Invest. Dermatol. 78(2), 108-115 (1982).
66. Kawaguchi Y, Mori N, Nakayama A: Kit+ melanocytes seem to contribute to melanocyte proliferation after UV exposure as precursor cells. J. Invest. Dermatol. 116(6), 920-925 (2001).
67. Grichnik JM, Ali WN. Burch JA et al.: KIT reveals a populadon of precursor melanocytes in human skin. J. Invest. Dermatol. 106(5), 967-971 (1996).
68. van Schanke A, Jongsma MJ, Bisschop R, van Venrooij GM, Rebel H, de Gruijl FR: Single UVB overexposure stimulates melanocyte proliferation in routine skin, in contrast to fractionated or UVA-1 exposure. J. Invest. Dermatol. 124, 241-247 (2005).
69. Billingham R, Silvers W: Studies on the migratory behaviour of melanocytes in guinea pig skin. J. Exp. Med. 131(1), 101-117 (1970).
70. Horikawa T, Mishima Y, Nishino K, Ichihashi M: Horizontal and vertical pigment spread into surrounding piebald epidermis and hair follicles after suction blister epidermal grafting. Pigment Cell Res. 12(3), 175-180 (1999).
71. Nishimura EK, Jordan SA, Oshima H et al.: Dominant role of the niche in melanocyte stem-cell fate determination. Nature 416(6883), 854-860 (2002).
72. Yonetani S, Moriyama M, Nishigori C, Osawa M, Nishikawa S: In vitro expansion of immature melanoblasts and their ability to repopulate melanocyte stem cells in the hair follicle. J. Invest. Dermatol. 128(2), 408-420 (2008).
73. Grichnik JM, Burch JA, Burchette J, Shea CR: The SCF/Kit pathway plays a critical role in control of normal human melanocyte homeostasis. J. Invest. Dermatol. 111(2), 233-238 (1998).
74. Silver W, Mintz B: Differences in latency and inducibility of mouse skin melanomas depending on the age and anatomic site of the skin. Cancer Res. 58(4), 630-632 (1998).
75. Rivers R: Is there more than one road to melanoma? Lancet 363(9410), 728-730 (2004).
76. Imokawa G: Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell Res. 17(2), 96-110 (2004).
77. Berking C, Takemoto R, Satymoorthy K: et al.: Induction of melanoma phenotypes in human skin by growth factors and ultraviolet B. Cancer Res. 64 (3), 807-811 (2004).
78. Young AR, Potten CS, Nikaido O et al.: Human melanocytes and keratinocytes exposed to UVB or UVA in vivo show comparable levels of thymine dimers. J. Invest. Dermatol. 111(6), 936-940 (1998)
79. Kraemer KH, Lee MM, Andrews AD, Lambert WC: The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch. Dermatol. 130(8), 1018-1021 (1994).
80. Yang G, Curley D, Bosenberg M, Tsao H: Loss of xeroderma pigmentosum C (Xpc) enhances melanoma photocarcinogenesis in Ink4a-Arf-deficient mice. Cancer Res. 67(12), 5649-5657 (2007).
81. Spatz A, Giglia-Mari G, Benhamou S, Sarasin A: Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum. Cancer Res. 61(6), 2480-2486 (2001).
82. Hocker T, Tsao H: Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants. Hum. Mutat. 28(6), 578-588 (2007).
83. Xu G, Snellman E, Bykov VJ, Jansen CT, Hemminki K: Cutaneous melanoma patients have normal repair kinetics of ultraviolet-induced DNA repair in skin in situ. J. Invest. Dermatol. 114(4), 628-631 (2000).
84. Dhomen N, Marais R: New insights into BRAF mutations in cancer. Curr. Opin. Genet. Dev. 17(1), 31-39. 2007.
85. Runger T, Kappes U: Mechanisms of mutation formation with long-wave ultraviolet radiation (UVA). Photoderm. Photommunol. Photomed. 24, 2-10 (2008).
86. Mitchell D, Paniker L, Sanchez G, Trono D, Nairn R: The etiology of sunlight-induced melanoma in Xiphophorus hybrid fish. Mol. Carcinog. 46(8), 679-684 (2007).
87. De Fabo EC, Noonan FP, Fears T, Merlino G: Ultraviolet B but not ultraviolet A radiation initiates melanoma. Cancer Res. 64(18), 6372-6376 (2004).
88. Yamaguchi Y, Takahashi K, Zmudzka BZ et al.: Human skin responses to UV radiation: pigment in the upper epidermis protects against DNA damage in the lower epidermis and facilitates apoptosis. FASEB J. 20(9), 1486-1488 (2006).
89. Donawho CK, Muller HK, Bucana CD, Kripke ML: Enhanced growth of murine melanoma in ultraviolet-irradiated skin is associated with local inhibition of immune effector mechanisms. J. Immunol. 157(2), 781-786 (1996).
90. Bastiaannet E, Homan-van der Heide JJ, Ploeg RJ, Hoekstra HJ: No increase of melanoma after kidney transplantation in the northern part of The Netherlands. Melanoma Res. 17(6), 349-353 (2007).
91. Jans J, Garinis GA, Schul W et al.: Differential role of basal keratinocytes in UV-induced immunosuppression and skin cancer. Mol. Cell. Biol. 26(22), 8515-8526 (2006).
92. Cui R, Widlund HR, Feige E et al.: Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 128(5), 853-886 (2007).
93. Zbytek B, Wortsman J, Slominski A: Characterization of an ultraviolet B-induced corticotropin-releasing hormone-proopiomelanocortin system in human melanocytes. Mol. Endocrinol. 20(10), 2539-2547 (2006)
94. Kunisada T, Lu SZ, Yoshida H et al.: Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor. J. Exp. Med. 187(10), 1565-1573 (1998).
95. Schwarz A, Stander S, Berneburg M et al.: Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair. Nat. Cell Biol. 4(1), 26-31 (2002).
96. Schwarz A, Maeda A, Stander S, van Steeg H, and Schwarz T: IL-18 reduces ultraviolet radiation-induced DNA damage and thereby affects photoimmunosuppression. J. Immunol. 176(5) 2896-2901 (2006).
97. Hue J, Kim A, Song H et al.: IL-18 enhances SCF production of melanoma cells by regulating ROI and p38 MAPK activity. Immunol. Lett. 96(2), 211-217 (2005).
98. Enk CD, Jacob-Hirsch J, Gal H et al.: The UVB-induced gene expression profile of human epidermis in vivo is different from that of cultured keratinocytes. Oncogene 25(18), 2601-2614 (2006).
99. Candille SI, Kaelin CB, Cattanach BM et al.: A β-defensin mutation causes black coat color in domestic dogs. Science 318(5855), 1418-1423 (2007):
100. Schatton T, Franks. M: Cancer stem cells and human malignant melanoma. Pigment Cell Melanoma Res. 21(1), 39-55 (2005).
101. Nishimura EK, Granter SR, Fisher DE: Mechanisms of hair greying: incomplete melanocyre stem cell maintenance in the niche. Science 307(5710), 720-724 (2005).
102. Gerdes M, Yuspa S: The contribution of epidermal stem cells to skin cancer. Stem Cell Rev. 1(3), 225-232 (2005).
103. Kangsamaksin T, Park HJ, Trempus CS, Morris RJ: A perspective on murine keratinocyte stem cells as targets of chemically induced skin cancer. Mol. Carcinog. 46(8), 579-584 (2007).
104. Brown KM, Macgregor S, Montgomery GW et al.: Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat. Genet. 40(7), 838-840 (2008).